NEW YORK, Oct. 06, 2025 (GLOBE NEWSWIRE) -- WHY: New York, N.Y., October 6, 2025. Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Nutex Health Inc. (NASDAQ: NUTX) between August 8, 2024 and August 14, 2025, both dates inclusive (the “Class Period”), of the important October 21, 2025 lead plaintiff deadline. SO WHAT: If you purchased Nutex securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a ...

Core Insights - Nutex Health Inc. announced it received 20 awards and honors in Q3 2025, marking the highest number in the company's history [1] - The recognition is attributed to the company's focus on patient care, which is central to its operations [2] - Awards reflect community votes, indicating high patient satisfaction and service quality [3] Awards and Recognitions - Albuquerque ER & Hospital: Best Emergency Room/Urgent Care, Best Place to Work, Best Pediatric Emergency Room, Best Community Health [4] - Green Bay ER & Hospital: Best Hospital/Medical Center [4] - Tucson ER & Hospital: Best Emergency Room, Best Hospital, Best Children's Medical Center, Best Emergency Care [4] - New Braunfels ER & Hospital: Best Hospital [4] - Texarkana Emergency Center and Hospital: Best Emergency Care, Best Hospital [4] - NW Indiana ER & Hospital: Best Hospital [4] - Oklahoma ER & Hospital: CIHQ Accreditation [4] - Starkey Ranch ER & Hospital: Horizon Award for Excellence in Patient Financial Experience [5] - Nutex Health ranked No. 2 in Houston's Top Performing Companies [5] Company Overview - Nutex Health Inc. is headquartered in Houston, Texas, and was founded in 2011 [5] - The company operates two divisions: Hospital Division and Population Health Management Division [6] - The Hospital Division manages 24 facilities across 11 states, focusing on innovative healthcare models [6]

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Nutex To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Nutex between August 8, 2024 and August 15, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Oct. 05, 2025 (GLOBE NEWSWIRE) -- Faruqi & Far ...

NEW YORK, Oct. 03, 2025 (GLOBE NEWSWIRE) -- If you have suffered a loss on your Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ:NUTX) investment, contact Thomas W. Elrod of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below to discuss your rights or interests in the securities fraud class action lawsuit at no cost. Investors have until October 21, 2025 to ask the Court to appoint them as lead plaintiff. [CONTACT THE FIRM IF YOU SUFFERED A LOSS] What Happened? O ...

Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating i ...

NEW YORK, Oct. 03, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Nutex Health Inc. (NASDAQ: NUTX) between August 8, 2024 and August 14, 2025, both dates inclusive (the “Class Period”), of the important October 21, 2025 lead plaintiff deadline. SO WHAT: If you purchased Nutex securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHA ...

LOS ANGELES, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming October 21, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX) securities between August 8, 2024 and August 14, 2025, inclusive (the “Class Period”). IF YOU SUFFERED A LOSS ON YOUR NUTEX INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECO ...

Core Points - A class action lawsuit has been filed against Nutex Health Inc. for allegedly making materially false and misleading statements regarding its business operations and financial prospects during the Class Period from August 8, 2024, to August 14, 2025 [8] - The lawsuit claims that Nutex engaged in fraudulent activities through its partnership with HaloMD, leading to unsustainable revenue and overstated financial health [3] - Investors who suffered losses during the specified period are encouraged to contact Bragar Eagel & Squire for legal options [4] Allegation Details - The complaint alleges that Nutex's management made false statements about the company's business and operations, including the success of its arbitration results with HaloMD [3] - It is claimed that Nutex overstated its ability to remediate internal control weaknesses and improperly classified stock-based compensation obligations [3] - The allegations suggest that these misrepresentations increased the risk of delayed financial reporting to the SEC and inflated the company's financial prospects [3] Next Steps - Investors who purchased Nutex shares and experienced losses are invited to reach out to the law firm for more information or to discuss their rights [4] - The deadline for investors to apply to be appointed as lead plaintiff in the lawsuit is October 21, 2025 [8]

Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com. As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) HaloMD was achieving lucrative arbitration results for Nutex by engaging in a ...

DEADLINE: October 27, 2025 CASE DETAILS: According to the Complaint, the Company made false and misleading statements to the market. LifeMD raised its guidance for fiscal year 2025 while ignoring important factors like customer acquisition costs. Based on these facts, LifeMD's public statements were false and materially misleading throughout the class period. If you are a shareholder who suffered a loss, contact us to participate . NEXT STEPS FOR SHAREHOLDERS : Once you register as a shareholder who purchas ...